Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Matthews

Showing results (1171-1180 of 1,238) with videos related to

Pageof 124
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 16, 2013
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: strategies to eliminate reactive metabolitesSajiv K Nair, Jean J Matthews, Stephan J Cripps, et al.
Molecular Cancer Therapeutics|March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayPeiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Science (New York, N.Y.)|October 3, 2024
The global loss of avian functional and phylogenetic diversity from anthropogenic extinctionsThomas J Matthews, Kostas A Triantis, Joseph P Wayman, et al.
Scientific Reports|April 22, 2016
Electrostatically-guided inhibition of Curli amyloid nucleation by the CsgC-like family of chaperonesJonathan D Taylor, William J Hawthorne, Joanne Lo, et al.
European Heart Journal|December 6, 2013
Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort studyNehal N Mehta, Gregory J Matthews, Parasuram Krishnamoorthy, et al.
The Journal of Infectious Diseases|May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation GroupM L Clements-Mann, K Weinhold, T J Matthews, et al.
Molecular Cancer Therapeutics|February 1, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor ModelsPaul Foster, Kyoko Yamaguchi, Pin P Hsu, et al.
Animal Cognition|September 20, 2011
How does cognition evolve? Phylogenetic comparative psychologyEvan L MacLean, Luke J Matthews, Brian A Hare, et al.
Sexually Transmitted Infections|June 29, 2026
Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in AustraliaCaroline G Watts, Louise M Causer, Susan J Matthews, et al.
Expert Review of Molecular Diagnostics|December 25, 2024
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote AustraliaTanya L Applegate, Louise M Causer, Ineka Gow, et al.
Pageof 124

Showing results (1171-1180 of 1,238) with videos related to

Sort By:
Pageof 124
Bioorganic & Medicinal Chemistry Letters|March 16, 2013
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: strategies to eliminate reactive metabolitesSajiv K Nair, Jean J Matthews, Stephan J Cripps, et al.
Molecular Cancer Therapeutics|March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayPeiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Science (New York, N.Y.)|October 3, 2024
The global loss of avian functional and phylogenetic diversity from anthropogenic extinctionsThomas J Matthews, Kostas A Triantis, Joseph P Wayman, et al.
Scientific Reports|April 22, 2016
Electrostatically-guided inhibition of Curli amyloid nucleation by the CsgC-like family of chaperonesJonathan D Taylor, William J Hawthorne, Joanne Lo, et al.
European Heart Journal|December 6, 2013
Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort studyNehal N Mehta, Gregory J Matthews, Parasuram Krishnamoorthy, et al.
The Journal of Infectious Diseases|May 21, 1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation GroupM L Clements-Mann, K Weinhold, T J Matthews, et al.
Molecular Cancer Therapeutics|February 1, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor ModelsPaul Foster, Kyoko Yamaguchi, Pin P Hsu, et al.
Animal Cognition|September 20, 2011
How does cognition evolve? Phylogenetic comparative psychologyEvan L MacLean, Luke J Matthews, Brian A Hare, et al.
Sexually Transmitted Infections|June 29, 2026
Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in AustraliaCaroline G Watts, Louise M Causer, Susan J Matthews, et al.
Expert Review of Molecular Diagnostics|December 25, 2024
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote AustraliaTanya L Applegate, Louise M Causer, Ineka Gow, et al.
Pageof 124